Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2006-05-23

AUTHORS

Pilar Carrasco Garrido, Javier de Miguel Díez, Javier Rejas Gutiérrez, Antonio Martín Centeno, Elena Gobartt Vázquez, Ángel Gil de Miguel, Marta García Carballo, Rodrigo Jiménez García

ABSTRACT

BackgroundCOPD is currently the fourth cause of morbidity and mortality in the developed world. Patients with COPD experience a progressive deterioration and disability, which lead to a worsening in their health-related quality of life (HRQoL). The aim of this work is to assess the Health-Related Quality of Life (HRQoL) of patients with stable COPD followed in primary care and to identify possible predictors of disease.MethodsIt is a multicenter, epidemiological, observational, descriptive study. Subjects of both sexes, older than 40 years and diagnosed of COPD at least 12 months before starting the study were included. Sociodemographic data, severity of disease, comorbidity, and use of health resources in the previous 12 months were collected. All patients were administered a generic quality-of-life questionnaire, the SF-12, that enables to calculate two scores, the physical (PCS-12) and the mental (MCS-12) component summary scores.Results10,711 patients were evaluated (75.6% men, 24.4% women), with a mean age of 67.1 years (SD 9.66). The mean value of FEV1 was 35.9 ± 10.0%. Mean PCS-12 and MCS-12 scores were 36.0 ± 9.9 and 48.3 ± 10.9, respectively. Compared to the reference population, patients with COPD had a reduction of PCS-12, even in mild stages of the disease. The correlation with FEV1 was higher for PCS-12 (r = 0.38) than for MCS-12 (r = 0.12). Predictors for both HRQoL components were sex, FEV1, use of oxygen therapy, and number of visits to emergency rooms and hospital admissions. Other independent predictors of PCS-12 were age, body mass index and educational level.ConclusionPatients with stable COPD show a reduction of their HRQoL, even in mild stages of the disease. The factors determining the HRQoL include sex, FEV1, use of oxygen therapy, and number of visits to emergency rooms and hospital admissions. More... »

PAGES

31

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1477-7525-4-31

DOI

http://dx.doi.org/10.1186/1477-7525-4-31

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1035806986

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/16719899


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Age Factors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cohort Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Comorbidity", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Progression", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Emergency Service, Hospital", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hospitalization", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mass Screening", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oxygen Inhalation Therapy", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Primary Health Care", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pulmonary Disease, Chronic Obstructive", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Quality of Life", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sickness Impact Profile", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Spain", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Preventive Medicine and Public Health Department, Universidad Rey Juan Carlos, Alcorc\u00f3n, Madrid, Spain", 
          "id": "http://www.grid.ac/institutes/grid.28479.30", 
          "name": [
            "Preventive Medicine and Public Health Department, Universidad Rey Juan Carlos, Alcorc\u00f3n, Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Garrido", 
        "givenName": "Pilar Carrasco", 
        "id": "sg:person.014622424221.65", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014622424221.65"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Pneumology, University Hospital Gregorio Mara\u00f1\u00f3n, Madrid, Spain", 
          "id": "http://www.grid.ac/institutes/grid.410526.4", 
          "name": [
            "Department of Pneumology, University Hospital Gregorio Mara\u00f1\u00f3n, Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "D\u00edez", 
        "givenName": "Javier de Miguel", 
        "id": "sg:person.01163270142.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163270142.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Health Outcomes Research, Medical Unit, Pfizer Espa\u00f1a, Parque Empresarial La Moraleja, Avda de Europa, 20-B, 28108, Alcobendas, Madrid, Spain", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Health Outcomes Research, Medical Unit, Pfizer Espa\u00f1a, Parque Empresarial La Moraleja, Avda de Europa, 20-B, 28108, Alcobendas, Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Guti\u00e9rrez", 
        "givenName": "Javier Rejas", 
        "id": "sg:person.011263155365.25", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011263155365.25"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Respiratory Area, Medical Unit, Pfizer Espa\u00f1a, Alcobendas, Madrid, Spain", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Respiratory Area, Medical Unit, Pfizer Espa\u00f1a, Alcobendas, Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Centeno", 
        "givenName": "Antonio Mart\u00edn", 
        "id": "sg:person.0667345553.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667345553.13"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical Department, Boehringer Ingelheim SA, Sant Cugat del Vall\u00e9s, Barcelona, Spain", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medical Department, Boehringer Ingelheim SA, Sant Cugat del Vall\u00e9s, Barcelona, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "V\u00e1zquez", 
        "givenName": "Elena Gobartt", 
        "id": "sg:person.010527056503.15", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010527056503.15"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Preventive Medicine and Public Health Department, Universidad Rey Juan Carlos, Alcorc\u00f3n, Madrid, Spain", 
          "id": "http://www.grid.ac/institutes/grid.28479.30", 
          "name": [
            "Preventive Medicine and Public Health Department, Universidad Rey Juan Carlos, Alcorc\u00f3n, Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "de Miguel", 
        "givenName": "\u00c1ngel Gil", 
        "id": "sg:person.01112410703.71", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112410703.71"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Preventive Medicine and Public Health Department, Universidad Rey Juan Carlos, Alcorc\u00f3n, Madrid, Spain", 
          "id": "http://www.grid.ac/institutes/grid.28479.30", 
          "name": [
            "Preventive Medicine and Public Health Department, Universidad Rey Juan Carlos, Alcorc\u00f3n, Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Carballo", 
        "givenName": "Marta Garc\u00eda", 
        "id": "sg:person.014542057315.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014542057315.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Preventive Medicine and Public Health Department, Universidad Rey Juan Carlos, Alcorc\u00f3n, Madrid, Spain", 
          "id": "http://www.grid.ac/institutes/grid.28479.30", 
          "name": [
            "Preventive Medicine and Public Health Department, Universidad Rey Juan Carlos, Alcorc\u00f3n, Madrid, Spain"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Garc\u00eda", 
        "givenName": "Rodrigo Jim\u00e9nez", 
        "id": "sg:person.014312341103.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014312341103.13"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.2165/00019053-200523040-00005", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020260938", 
          "https://doi.org/10.2165/00019053-200523040-00005"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1023/a:1015520110663", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003308583", 
          "https://doi.org/10.1023/a:1015520110663"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2006-05-23", 
    "datePublishedReg": "2006-05-23", 
    "description": "BackgroundCOPD is currently the fourth cause of morbidity and mortality in the developed world. Patients with COPD experience a progressive deterioration and disability, which lead to a worsening in their health-related quality of life (HRQoL). The aim of this work is to assess the Health-Related Quality of Life (HRQoL) of patients with stable COPD followed in primary care and to identify possible predictors of disease.MethodsIt is a multicenter, epidemiological, observational, descriptive study. Subjects of both sexes, older than 40 years and diagnosed of COPD at least 12 months before starting the study were included. Sociodemographic data, severity of disease, comorbidity, and use of health resources in the previous 12 months were collected. All patients were administered a generic quality-of-life questionnaire, the SF-12, that enables to calculate two scores, the physical (PCS-12) and the mental (MCS-12) component summary scores.Results10,711 patients were evaluated (75.6% men, 24.4% women), with a mean age of 67.1 years (SD 9.66). The mean value of FEV1 was 35.9 \u00b1 10.0%. Mean PCS-12 and MCS-12 scores were 36.0 \u00b1 9.9 and 48.3 \u00b1 10.9, respectively. Compared to the reference population, patients with COPD had a reduction of PCS-12, even in mild stages of the disease. The correlation with FEV1 was higher for PCS-12 (r = 0.38) than for MCS-12 (r = 0.12). Predictors for both HRQoL components were sex, FEV1, use of oxygen therapy, and number of visits to emergency rooms and hospital admissions. Other independent predictors of PCS-12 were age, body mass index and educational level.ConclusionPatients with stable COPD show a reduction of their HRQoL, even in mild stages of the disease. The factors determining the HRQoL include sex, FEV1, use of oxygen therapy, and number of visits to emergency rooms and hospital admissions.", 
    "genre": "article", 
    "id": "sg:pub.10.1186/1477-7525-4-31", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1031326", 
        "issn": [
          "1477-7525"
        ], 
        "name": "Health and Quality of Life Outcomes", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "4"
      }
    ], 
    "keywords": [
      "health-related quality", 
      "PCS-12", 
      "stable COPD", 
      "oxygen therapy", 
      "hospital admission", 
      "emergency room", 
      "number of visits", 
      "mild stage", 
      "mental component summary scores", 
      "chronic obstructive pulmonary disease", 
      "mean PCS-12", 
      "MCS-12 scores", 
      "obstructive pulmonary disease", 
      "component summary scores", 
      "body mass index", 
      "severity of disease", 
      "quality of life", 
      "independent predictors", 
      "pulmonary disease", 
      "mass index", 
      "SF-12", 
      "mean age", 
      "MCS-12", 
      "HRQoL components", 
      "primary care", 
      "Life Questionnaire", 
      "fourth cause", 
      "COPD", 
      "summary scores", 
      "patients", 
      "sociodemographic data", 
      "FEV1", 
      "progressive deterioration", 
      "possible predictors", 
      "generic quality", 
      "health resources", 
      "disease", 
      "descriptive study", 
      "HRQoL", 
      "admission", 
      "reference population", 
      "therapy", 
      "sex", 
      "educational level", 
      "scores", 
      "predictors", 
      "visits", 
      "months", 
      "age", 
      "BackgroundCOPD", 
      "multicenter", 
      "ConclusionPatients", 
      "comorbidities", 
      "morbidity", 
      "mean value", 
      "MethodsIt", 
      "worsening", 
      "years", 
      "mortality", 
      "severity", 
      "care", 
      "study", 
      "life", 
      "disability", 
      "cause", 
      "health", 
      "questionnaire", 
      "subjects", 
      "use", 
      "reduction", 
      "room", 
      "aim", 
      "quality", 
      "population", 
      "stage", 
      "deterioration", 
      "negative impact", 
      "index", 
      "levels", 
      "factors", 
      "number", 
      "correlation", 
      "data", 
      "impact", 
      "results", 
      "values", 
      "components", 
      "world", 
      "resources", 
      "work"
    ], 
    "name": "Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study", 
    "pagination": "31", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1035806986"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1477-7525-4-31"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "16719899"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1477-7525-4-31", 
      "https://app.dimensions.ai/details/publication/pub.1035806986"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-10-01T06:33", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_425.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1186/1477-7525-4-31"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1477-7525-4-31'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1477-7525-4-31'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1477-7525-4-31'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1477-7525-4-31'


 

This table displays all metadata directly associated to this object as RDF triples.

297 TRIPLES      21 PREDICATES      137 URIs      126 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1477-7525-4-31 schema:about N001cf12942ab4795a7f497afd479a5db
2 N0eb322b2ceb54f7aa89129ddac1c2a9e
3 N1273d2ae420f44b9972bdbd696fdb26d
4 N152cc3272f214bcc933cdab1bd2f2ca8
5 N1aa074dd358940908358aef6f7e0ecd0
6 N39f3734c57f14b7c95ac9d3e308b21ec
7 N48df395b6b2c4580baaef72b24b6ef45
8 N6b177ecb00164db8a034298ef66ac596
9 N731394be41514c1496d5631337fa0ccd
10 N8af5b813011c4e928de4bb6db38f8989
11 Nbb4eb3cc92ea42278c8c0b40ac1ee1ab
12 Nbf022217afd1415ea943f16f22174a0c
13 Nbf46ea51a4074775b4ad14309124fe4c
14 Nc77bf85df5124e56933736e90ebdb8e2
15 Nd110fb0861df45b58b9437e2bddeb4d9
16 Nd879c6493d9e44a58fa2c35ddacf6191
17 Ne6af7ff33c3747a59824ff6d3ca1bb9a
18 Ne96fa8c5167d491eb25555dd59275416
19 Nff33f99e6bee4e7e84c07b500ece3d4b
20 anzsrc-for:11
21 anzsrc-for:1102
22 anzsrc-for:1117
23 schema:author Nefbf99ab56db4f9bad71ef2726ff0227
24 schema:citation sg:pub.10.1023/a:1015520110663
25 sg:pub.10.2165/00019053-200523040-00005
26 schema:datePublished 2006-05-23
27 schema:datePublishedReg 2006-05-23
28 schema:description BackgroundCOPD is currently the fourth cause of morbidity and mortality in the developed world. Patients with COPD experience a progressive deterioration and disability, which lead to a worsening in their health-related quality of life (HRQoL). The aim of this work is to assess the Health-Related Quality of Life (HRQoL) of patients with stable COPD followed in primary care and to identify possible predictors of disease.MethodsIt is a multicenter, epidemiological, observational, descriptive study. Subjects of both sexes, older than 40 years and diagnosed of COPD at least 12 months before starting the study were included. Sociodemographic data, severity of disease, comorbidity, and use of health resources in the previous 12 months were collected. All patients were administered a generic quality-of-life questionnaire, the SF-12, that enables to calculate two scores, the physical (PCS-12) and the mental (MCS-12) component summary scores.Results10,711 patients were evaluated (75.6% men, 24.4% women), with a mean age of 67.1 years (SD 9.66). The mean value of FEV1 was 35.9 ± 10.0%. Mean PCS-12 and MCS-12 scores were 36.0 ± 9.9 and 48.3 ± 10.9, respectively. Compared to the reference population, patients with COPD had a reduction of PCS-12, even in mild stages of the disease. The correlation with FEV1 was higher for PCS-12 (r = 0.38) than for MCS-12 (r = 0.12). Predictors for both HRQoL components were sex, FEV1, use of oxygen therapy, and number of visits to emergency rooms and hospital admissions. Other independent predictors of PCS-12 were age, body mass index and educational level.ConclusionPatients with stable COPD show a reduction of their HRQoL, even in mild stages of the disease. The factors determining the HRQoL include sex, FEV1, use of oxygen therapy, and number of visits to emergency rooms and hospital admissions.
29 schema:genre article
30 schema:isAccessibleForFree true
31 schema:isPartOf N66e944f914e04ab09e1071f5f26d318b
32 Nd0ce447c92134f03b4c3cdf333d9d430
33 sg:journal.1031326
34 schema:keywords BackgroundCOPD
35 COPD
36 ConclusionPatients
37 FEV1
38 HRQoL
39 HRQoL components
40 Life Questionnaire
41 MCS-12
42 MCS-12 scores
43 MethodsIt
44 PCS-12
45 SF-12
46 admission
47 age
48 aim
49 body mass index
50 care
51 cause
52 chronic obstructive pulmonary disease
53 comorbidities
54 component summary scores
55 components
56 correlation
57 data
58 descriptive study
59 deterioration
60 disability
61 disease
62 educational level
63 emergency room
64 factors
65 fourth cause
66 generic quality
67 health
68 health resources
69 health-related quality
70 hospital admission
71 impact
72 independent predictors
73 index
74 levels
75 life
76 mass index
77 mean PCS-12
78 mean age
79 mean value
80 mental component summary scores
81 mild stage
82 months
83 morbidity
84 mortality
85 multicenter
86 negative impact
87 number
88 number of visits
89 obstructive pulmonary disease
90 oxygen therapy
91 patients
92 population
93 possible predictors
94 predictors
95 primary care
96 progressive deterioration
97 pulmonary disease
98 quality
99 quality of life
100 questionnaire
101 reduction
102 reference population
103 resources
104 results
105 room
106 scores
107 severity
108 severity of disease
109 sex
110 sociodemographic data
111 stable COPD
112 stage
113 study
114 subjects
115 summary scores
116 therapy
117 use
118 values
119 visits
120 work
121 world
122 worsening
123 years
124 schema:name Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study
125 schema:pagination 31
126 schema:productId N5061db69a9e941328b23ff8630cfba8d
127 Nc90a9f26324543ca84b02b67517985d8
128 Nd71be4f8f07e497e8a090ddee94b580b
129 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035806986
130 https://doi.org/10.1186/1477-7525-4-31
131 schema:sdDatePublished 2022-10-01T06:33
132 schema:sdLicense https://scigraph.springernature.com/explorer/license/
133 schema:sdPublisher N7c2a8e4eb4734ec0b13019b480aaea6d
134 schema:url https://doi.org/10.1186/1477-7525-4-31
135 sgo:license sg:explorer/license/
136 sgo:sdDataset articles
137 rdf:type schema:ScholarlyArticle
138 N001cf12942ab4795a7f497afd479a5db schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Disease Progression
140 rdf:type schema:DefinedTerm
141 N0eb322b2ceb54f7aa89129ddac1c2a9e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Aged
143 rdf:type schema:DefinedTerm
144 N1273d2ae420f44b9972bdbd696fdb26d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Middle Aged
146 rdf:type schema:DefinedTerm
147 N152cc3272f214bcc933cdab1bd2f2ca8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Spain
149 rdf:type schema:DefinedTerm
150 N1850d2e3e68240a8be0f2f1d65d41d89 rdf:first sg:person.01163270142.12
151 rdf:rest N906d6e30fce84ded82c2df902d212b75
152 N1aa074dd358940908358aef6f7e0ecd0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Female
154 rdf:type schema:DefinedTerm
155 N207d0e3674cf49089c6eae79757cf269 rdf:first sg:person.014312341103.13
156 rdf:rest rdf:nil
157 N34e55bfa615745cd989bb6ce6e5dfd45 rdf:first sg:person.014542057315.23
158 rdf:rest N207d0e3674cf49089c6eae79757cf269
159 N39f3734c57f14b7c95ac9d3e308b21ec schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
160 schema:name Male
161 rdf:type schema:DefinedTerm
162 N48df395b6b2c4580baaef72b24b6ef45 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
163 schema:name Pulmonary Disease, Chronic Obstructive
164 rdf:type schema:DefinedTerm
165 N5061db69a9e941328b23ff8630cfba8d schema:name doi
166 schema:value 10.1186/1477-7525-4-31
167 rdf:type schema:PropertyValue
168 N66e944f914e04ab09e1071f5f26d318b schema:issueNumber 1
169 rdf:type schema:PublicationIssue
170 N68be391dfe4247ec901bb41d5617ee4b rdf:first sg:person.01112410703.71
171 rdf:rest N34e55bfa615745cd989bb6ce6e5dfd45
172 N6b177ecb00164db8a034298ef66ac596 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
173 schema:name Humans
174 rdf:type schema:DefinedTerm
175 N731394be41514c1496d5631337fa0ccd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
176 schema:name Comorbidity
177 rdf:type schema:DefinedTerm
178 N7c2a8e4eb4734ec0b13019b480aaea6d schema:name Springer Nature - SN SciGraph project
179 rdf:type schema:Organization
180 N8af5b813011c4e928de4bb6db38f8989 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
181 schema:name Sickness Impact Profile
182 rdf:type schema:DefinedTerm
183 N906d6e30fce84ded82c2df902d212b75 rdf:first sg:person.011263155365.25
184 rdf:rest N972c7df2ccac48f38214117b8f300de7
185 N972c7df2ccac48f38214117b8f300de7 rdf:first sg:person.0667345553.13
186 rdf:rest Na9f88fd2d249496cb4aaa809c8d48ce2
187 Na9f88fd2d249496cb4aaa809c8d48ce2 rdf:first sg:person.010527056503.15
188 rdf:rest N68be391dfe4247ec901bb41d5617ee4b
189 Nbb4eb3cc92ea42278c8c0b40ac1ee1ab schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Age Factors
191 rdf:type schema:DefinedTerm
192 Nbf022217afd1415ea943f16f22174a0c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
193 schema:name Primary Health Care
194 rdf:type schema:DefinedTerm
195 Nbf46ea51a4074775b4ad14309124fe4c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
196 schema:name Adult
197 rdf:type schema:DefinedTerm
198 Nc77bf85df5124e56933736e90ebdb8e2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
199 schema:name Cohort Studies
200 rdf:type schema:DefinedTerm
201 Nc90a9f26324543ca84b02b67517985d8 schema:name pubmed_id
202 schema:value 16719899
203 rdf:type schema:PropertyValue
204 Nd0ce447c92134f03b4c3cdf333d9d430 schema:volumeNumber 4
205 rdf:type schema:PublicationVolume
206 Nd110fb0861df45b58b9437e2bddeb4d9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
207 schema:name Emergency Service, Hospital
208 rdf:type schema:DefinedTerm
209 Nd71be4f8f07e497e8a090ddee94b580b schema:name dimensions_id
210 schema:value pub.1035806986
211 rdf:type schema:PropertyValue
212 Nd879c6493d9e44a58fa2c35ddacf6191 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
213 schema:name Oxygen Inhalation Therapy
214 rdf:type schema:DefinedTerm
215 Ne6af7ff33c3747a59824ff6d3ca1bb9a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
216 schema:name Quality of Life
217 rdf:type schema:DefinedTerm
218 Ne96fa8c5167d491eb25555dd59275416 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
219 schema:name Hospitalization
220 rdf:type schema:DefinedTerm
221 Nefbf99ab56db4f9bad71ef2726ff0227 rdf:first sg:person.014622424221.65
222 rdf:rest N1850d2e3e68240a8be0f2f1d65d41d89
223 Nff33f99e6bee4e7e84c07b500ece3d4b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
224 schema:name Mass Screening
225 rdf:type schema:DefinedTerm
226 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
227 schema:name Medical and Health Sciences
228 rdf:type schema:DefinedTerm
229 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
230 schema:name Cardiorespiratory Medicine and Haematology
231 rdf:type schema:DefinedTerm
232 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
233 schema:name Public Health and Health Services
234 rdf:type schema:DefinedTerm
235 sg:journal.1031326 schema:issn 1477-7525
236 schema:name Health and Quality of Life Outcomes
237 schema:publisher Springer Nature
238 rdf:type schema:Periodical
239 sg:person.010527056503.15 schema:affiliation grid-institutes:None
240 schema:familyName Vázquez
241 schema:givenName Elena Gobartt
242 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010527056503.15
243 rdf:type schema:Person
244 sg:person.01112410703.71 schema:affiliation grid-institutes:grid.28479.30
245 schema:familyName de Miguel
246 schema:givenName Ángel Gil
247 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01112410703.71
248 rdf:type schema:Person
249 sg:person.011263155365.25 schema:affiliation grid-institutes:None
250 schema:familyName Gutiérrez
251 schema:givenName Javier Rejas
252 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011263155365.25
253 rdf:type schema:Person
254 sg:person.01163270142.12 schema:affiliation grid-institutes:grid.410526.4
255 schema:familyName Díez
256 schema:givenName Javier de Miguel
257 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01163270142.12
258 rdf:type schema:Person
259 sg:person.014312341103.13 schema:affiliation grid-institutes:grid.28479.30
260 schema:familyName García
261 schema:givenName Rodrigo Jiménez
262 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014312341103.13
263 rdf:type schema:Person
264 sg:person.014542057315.23 schema:affiliation grid-institutes:grid.28479.30
265 schema:familyName Carballo
266 schema:givenName Marta García
267 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014542057315.23
268 rdf:type schema:Person
269 sg:person.014622424221.65 schema:affiliation grid-institutes:grid.28479.30
270 schema:familyName Garrido
271 schema:givenName Pilar Carrasco
272 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014622424221.65
273 rdf:type schema:Person
274 sg:person.0667345553.13 schema:affiliation grid-institutes:None
275 schema:familyName Centeno
276 schema:givenName Antonio Martín
277 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667345553.13
278 rdf:type schema:Person
279 sg:pub.10.1023/a:1015520110663 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003308583
280 https://doi.org/10.1023/a:1015520110663
281 rdf:type schema:CreativeWork
282 sg:pub.10.2165/00019053-200523040-00005 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020260938
283 https://doi.org/10.2165/00019053-200523040-00005
284 rdf:type schema:CreativeWork
285 grid-institutes:None schema:alternateName Department of Health Outcomes Research, Medical Unit, Pfizer España, Parque Empresarial La Moraleja, Avda de Europa, 20-B, 28108, Alcobendas, Madrid, Spain
286 Medical Department, Boehringer Ingelheim SA, Sant Cugat del Vallés, Barcelona, Spain
287 Respiratory Area, Medical Unit, Pfizer España, Alcobendas, Madrid, Spain
288 schema:name Department of Health Outcomes Research, Medical Unit, Pfizer España, Parque Empresarial La Moraleja, Avda de Europa, 20-B, 28108, Alcobendas, Madrid, Spain
289 Medical Department, Boehringer Ingelheim SA, Sant Cugat del Vallés, Barcelona, Spain
290 Respiratory Area, Medical Unit, Pfizer España, Alcobendas, Madrid, Spain
291 rdf:type schema:Organization
292 grid-institutes:grid.28479.30 schema:alternateName Preventive Medicine and Public Health Department, Universidad Rey Juan Carlos, Alcorcón, Madrid, Spain
293 schema:name Preventive Medicine and Public Health Department, Universidad Rey Juan Carlos, Alcorcón, Madrid, Spain
294 rdf:type schema:Organization
295 grid-institutes:grid.410526.4 schema:alternateName Department of Pneumology, University Hospital Gregorio Marañón, Madrid, Spain
296 schema:name Department of Pneumology, University Hospital Gregorio Marañón, Madrid, Spain
297 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...